Mereo Biopharma Group Plc(MREO)
$0.26-0.02 (-5.45%)
MREO
Mereo Biopharma Group Plc financials statements
$0.26
At close:-0.02 (-5.45%)
Want to see MREO full AI Analyst Report?
Mereo Biopharma Group Plc (MREO) Income Statement
897 Followers
Mereo Biopharma Group Plc Income Statement
Last quarter (Q3 2026), Mereo Biopharma Group Plc's total revenue was $800.00K. In Q3, Mereo Biopharma Group Plc's net income was $-5.86M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 500.00K | $ 0.00 | $ 10.00M | $ 0.00 | $ 36.46M | |
| $ 367.00K | $ -1.09M | $ 7.43M | $ 1.15M | $ 18.56M | |
| $ 38.62M | $ 47.36M | $ 35.84M | $ 55.57M | $ 39.49M | |
| Depreciation and Amortization | $ 1.15M | $ 1.09M | $ 1.06M | $ 889.00K | $ 642.00K |
| $ -40.47M | $ 1.09M | $ -26.06M | $ -37.87M | $ 18.91M | |
| $ -38.26M | $ -47.38M | $ -28.42M | $ -54.43M | $ -20.94M | |
| $ -3.62M | $ 4.11M | $ -1.58M | $ 11.49M | $ 35.18M | |
| $ -41.88M | $ -43.25M | $ -30.00M | $ -42.94M | $ 14.24M | |
| $ -41.88M | $ -43.25M | $ -29.47M | $ -42.22M | $ 12.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.26 | $ -0.30 | $ -0.22 | $ -1.80 | $ 0.10 |
| Diluted EPS | $ -0.26 | $ -0.30 | $ -0.22 | $ -1.80 | $ -0.25 |
| Weighted Average Shares Outstanding | 159.42M | 29.58M | 131.89M | 22.80M | 105.56M |
| Weighted Average Shares Outstanding (Diluted) | 159.42M | 29.58M | 131.89M | 22.80M | 111.06M |
Currency in USD

